Some users may notice initial improvements in energy levels and recovery within a few weeks, while more significant changes in muscle growth, fat loss, and overall body composition may take several months of consistent use
Recently, a working group from the International Consortium for Health Outcomes Measurement (ICHOM) made recommendations for a standard set of practical and validated psychosocial measures [179], including the WHO-5 Wellbeing Index (WHO-5) [180], Problem Areas in Diabetes (PAID) scale [181], and Patient Health Questionnaire (PHQ-9) [182]
How quickly can I expect results with a weight loss program
Insulin resistance and T2DM are increasingly recognized as chronic inflammatory diseases, with NF-B serving as a key regulatory factor in the development of insulin resistance [116]
Studies now show that patients on GLP-1 agonists face a nearly fourfold increased risk of gastroparesis (a chronic slowdown of the gut causing abdominal bloating and pain) and a ninefold increased risk of pancreatitis compared to people on other weight-loss medications
Immediate medical attention is required if taste changes are accompanied by: Severe, persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, decreased urination) Severe abdominal pain, particularly if persistent or worsening Symptoms of pancreatitis (severe upper abdominal pain radiating to the back, nausea, vomiting) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Symptoms of hypoglycemia (if also taking insulin or sulfonylureas): shakiness, sweating, confusion, irritability These symptoms may indicate serious adverse effects requiring urgent evaluation, including pancreatitis, gallbladder disease, gastroparesis, or severe dehydration